Bayer

Care/of heads to Target

24-Mar-2021 By Danielle Masterson

Since their launch in 2016, over 6 million people have taken their quiz. Now Care/of is taking their online insights and to a Target aisle near you.

Pantheryx acquires Bayer’s TruBiotics in effort to accelerate probiotic category

02-Mar-2021 By Danielle Masterson

Colostrum-based nutrition and biotechnology company Pantheryx has announced that it has acquired probiotic brand TruBiotics and its trademarks from Bayer HealthCare.

NutraCast Podcast: The Detox Project on Glyphosate Residue Free Certification

02-Oct-2020 By Danielle Masterson

The Detox Project is a research and certification platform that set up Glyphosate Residue Free Certification which aims to educate consumers about the dangers of this chemical entering the food and nutraceutical supply.

Multivitamin gummies: Experts share their tips on how to formulate them

07-May-2018 By Adi Menayang

Gummies are an increasingly popular delivery format for dietary supplements. We talk to some experts in the category on how to make sure a product isn’t sacrificing nutrient content over palatability.

Dietary supplement industry shift takes hold in 2015

16-Dec-2015 By Karen Howard, CEO and Executive Director, Organic & Natural Health Association

It has been proclaimed “nature abhors a vacuum.”  In the transition to modern times, this scientific theory is more commonly used to explain why inaction results in action. Perhaps the major events of the past year are the result of the natural products...

Mister: Bayer opinion is not a green light to just say whatever you want, but the opinion is a reassurance

13-Oct-2015 By Stephen Daniells

The recent decision in the Bayer vs FTC case contains positive lessons and some points of caution for the industry, notably around what you need to substantiate claims and why FTC is not going away, says Steve Mister, President and CEO of the CRN.

Bayer vs FTC: Not the battle of the experts many were expecting…

05-Oct-2015 By Stephen Daniells

The Bayer vs FTC case in the US District Court of New Jersey is full of lessons, including what does and does not constitute ‘competent and reliable scientific evidence’, and the importance of having experts who know the space.

UPDATED: NPA calls decision a "win for the industry and consumers"

‘A drug-level randomized controlled clinical trial for a supplement has never been the standard’: Bayer ‘gratified’ with court decision vs FTC

29-Sep-2015 By Stephen Daniells

The hotly anticipated decision in the dispute between Bayer and the US Federal Trade Commission over claims in support of Phillips’ Colon Health is in, with a judge ruling in favor of the company.

Bayer ‘extremely disappointed & strongly disagrees’ with FTC/DoJ allegations against Phillips’ Colon Health claims

12-Sep-2014 By Stephen Daniells

Healthcare giant Bayer has said it will defend itself ‘vigorously’ against the US Federal Trade Commission decision to bring a motion against the company for claims made for its probiotic dietary supplement, Phillips’ Colon Health.

FDA raps Bayer in ‘combo' product crackdown

29-Oct-2008 By Shane Starling

In a move that has divided industry, the Food and Drug Administration (FDA) has told German pharma giant Bayer in no uncertain terms to cease making disease reduction claims about products that contain both pharmaceutical and nutraceutical ingredients.